These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 24519508)

  • 81. Dexamethasone intravitreal implant for treatment of diabetic macular edema in vitrectomized patients.
    Boyer DS; Faber D; Gupta S; Patel SS; Tabandeh H; Li XY; Liu CC; Lou J; Whitcup SM;
    Retina; 2011 May; 31(5):915-23. PubMed ID: 21487341
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Desegmentation of Ozurdex implant in vitreous cavity: report of two cases.
    Agrawal R; Fernandez-Sanz G; Bala S; Addison PK
    Br J Ophthalmol; 2014 Jul; 98(7):961-3. PubMed ID: 24648417
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Suspected bacterial endophthalmitis following sustained-release dexamethasone intravitreal implant: a case report.
    Arıkan Yorgun M; Mutlu M; Toklu Y; Cakmak HB; Cağıl N
    Korean J Ophthalmol; 2014 Jun; 28(3):275-7. PubMed ID: 24882964
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Inadvertent Subconjunctival Injection of a Dexamethasone Implant.
    Fenolland JR; Sigaux M; Giraud JM
    JAMA Ophthalmol; 2017 May; 135(5):e170106. PubMed ID: 28494077
    [No Abstract]   [Full Text] [Related]  

  • 85. Long-term evaluation of dexamethasone intravitreal implant in vitrectomized and non-vitrectomized eyes with macular edema secondary to non-infectious uveitis.
    Pelegrín L; de la Maza MS; Molins B; Ríos J; Adán A
    Eye (Lond); 2015 Jul; 29(7):943-50. PubMed ID: 25998942
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Immortal Ozurdex: A 10-month follow-up of an intralenticular implant.
    Poornachandra B; Kumar VBM; Jayadev C; Dorelli SH; Yadav NK; Shetty R
    Indian J Ophthalmol; 2017 Mar; 65(3):255-257. PubMed ID: 28440260
    [TBL] [Abstract][Full Text] [Related]  

  • 87. INTRAVITREAL DEXAMETHASONE IMPLANT MIGRATION INTO THE ANTERIOR CHAMBER: A Multicenter Study From the Pan-American Collaborative Retina Study Group.
    Gonçalves MB; Alves BQ; Moura R; Magalhães O; Maia A; Belfort R; de Ávila MP; Zas M; Saravia M; Lousas M; Wu L; Arevalo JF; Pacheco KD; Johnson T; Farah ME; Rodriguez FJ; Maia M;
    Retina; 2020 May; 40(5):825-832. PubMed ID: 30789460
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Modified No-Touch Technique for Removal of a Dexamethasone Implant that has Migrated to the Anterior Chamber.
    Stewart JM
    Ocul Immunol Inflamm; 2020; 28(2):238-239. PubMed ID: 30556778
    [TBL] [Abstract][Full Text] [Related]  

  • 89. REAL-LIFE STUDY IN DIABETIC MACULAR EDEMA TREATED WITH DEXAMETHASONE IMPLANT: The Reldex Study.
    Malclès A; Dot C; Voirin N; Agard É; Vié AL; Bellocq D; Denis P; Kodjikian L
    Retina; 2017 Apr; 37(4):753-760. PubMed ID: 27471826
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Dexamethasone intravitreal implant for treatment of patients with recalcitrant macular edema resulting from Irvine-Gass syndrome.
    Dutra Medeiros M; Navarro R; Garcia-Arumí J; Mateo C; Corcóstegui B
    Invest Ophthalmol Vis Sci; 2013 May; 54(5):3320-4. PubMed ID: 23599334
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Ozurdex in the management of the macular edema following retinal vein occlusion in clinical practice.
    Matonti F; Meyer F; Guigou S; Barthelemy T; Dumas S; Gobert F; Hajjar C; Merite PY; Parrat E; Rouhette H; Pommier S
    Acta Ophthalmol; 2013 Nov; 91(7):e584-6. PubMed ID: 23764276
    [No Abstract]   [Full Text] [Related]  

  • 92. Dexamethasone intravitreal implant during phacoemulsification.
    Agarwal A; Gupta V; Ram J; Gupta A
    Ophthalmology; 2013 Jan; 120(1):211, 211.e1-5. PubMed ID: 23283186
    [No Abstract]   [Full Text] [Related]  

  • 93. Intractable glaucoma necessitating dexamethasone implant (Ozurdex) removal and glaucoma surgery in a child with uveitis.
    Kumari N; Parchand S; Kaushik S; Singh R
    BMJ Case Rep; 2013 Dec; 2013():. PubMed ID: 24311419
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Efficacy and Safety of Dexamethasone Intravitreal Implant for Treatment of Refractory Macular Edema Secondary to Retinal Vein Occlusion in Taiwan.
    Sheu SJ; Wu TT; Horng YH
    J Ocul Pharmacol Ther; 2015 Oct; 31(8):461-7. PubMed ID: 26067779
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Cauterization of Ozurdex wound for the prevention of scleral leakage in vitrectomized eyes.
    Furino C; Recchimurzo N; Boscia F; Alessio G
    Eur J Ophthalmol; 2018 May; 28(3):341-343. PubMed ID: 29108392
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Retrospective, observational study in patients receiving a dexamethasone intravitreal implant 0.7 mg for macular oedema secondary to retinal vein occlusion.
    Augustin AJ; Holz FG; Haritoglou C; Mayer WJ; Bopp S; Scheuerle AF; Maier M; Sekundo W; Sandner D; Shirlaw A; Hattenbach LO
    Ophthalmologica; 2015; 233(1):18-26. PubMed ID: 25503473
    [TBL] [Abstract][Full Text] [Related]  

  • 97. [A cost-effectiveness study of dexamethasone implants in macular edema].
    Lozano López V; Serrano García M; Mantolán Sarmiento C; Pareja Ríos A; Losada Castillo MJ; Cordovés Dorta L; Quijada Fumero E; Virgós Aller T; Bullejos Molina M
    Arch Soc Esp Oftalmol; 2015 Jan; 90(1):14-21. PubMed ID: 25443181
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Persistent triamcinolone acetonide particles on the posterior lens capsule after intravitreal injection.
    Sakalar YB; Unlu K; Keklikci U; Caca I; Senol BB
    Ann Ophthalmol (Skokie); 2008; 40(3-4):190-2. PubMed ID: 19230363
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Management of iatrogenic crystalline lens injury occurred during intravitreal injection.
    Erdogan G; Gunay BO; Unlu C; Gunay M; Ergin A
    Int Ophthalmol; 2016 Aug; 36(4):527-30. PubMed ID: 26631401
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Simple technique for management of anterior chamber-migrated Ozurdex
    Lee SH; Kang H; Byeon SH; Kim SS; Koh HJ; Lee SC; Kim M
    Acta Ophthalmol; 2018 Nov; 96(7):e893-e894. PubMed ID: 29030918
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.